Back to 
ZACKS INVESTMENT MANAGEMENT
ZACKS INVESTMENT MANAGEMENT
CYTK
Showing 0 of 3 quarters
Position history for ZACKS INVESTMENT MANAGEMENT's holdings in CYTOKINETICS INC
No. Zacks Investment Management exited its CYTK (Cytokinetics) position in Q3 2019. Its Q2 2019 13F listed 10,981 shares worth $124,000. Zacks Investment Management already held CYTK in its Q1 2019 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.